Published: 2022-05-24

Visceral obesity assessment in type 2 diabetes mellitus using a body shape index may be better as compared to body mass index

Suhas Maddodi, S. K. Gautam


Background: Body mass index (BMI) is being widely used to assess obesity and associated cardiovascular risk but found to be deficient of assessing visceral obesity for which ABSI was developed. Aim and objectives were to determine a body shape index (ABSI) as a better marker than BMI in assessing visceral obesity in type 2 diabetes mellitus (T2DM) patients.

Methods: The present cross-sectional study consisted total 150 patients over 40-year age, both male (90) and menopaused female (60). USG was used to measure the visceral obesity.

Results: The area under the ROC curve (AUROC) for BMI (kg/m²) predicting V/S fat ratio: >2.5 vs V/S fat ratio: <2.5 was 0.593 (95% CI: 0.5-0.685), thus demonstrating poor diagnostic performance compared to ABSI which was 0.815 (95% CI: 0.748-0.882), thus demonstrating good diagnostic performance.

Conclusions: ABSI was better in assessing visceral obesity compared to BMI so can be used along with other markers in assessing cardiovascular risk.


Type 2 diabetes mellitus, Obesity, ABSI, BMI, Waist circumference, ABSI z-score

Full Text:



Afshin A. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377:13-27.

Hill JH, Solt C, Foster MT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm Mol Biol Clin Investig. 2018;33(2).

Ding C, Chan Z, Magkos F. Lean, but not healthy: the “metabolically obese, normal-weight” phenotype. Curr. Opin Clin Nutr Metab Care. 2016;19:408-17.

Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 2019;92:51-60.

Schulze MB. Metabolic health in normal-weight and obese individuals. Diabetologia. 2019;62:558-66.

Stefan N, Haring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152-62.

Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7:e39504.

Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, Marchi M et al. Sonography detection of small intra-abdominal fat variations. Int J Obesity. 1991;15:847-52.

Gažarová M, Galšneiderová M, Mečiarová L. Obesity diagnosis and mortality risk based on a body shape index (ABSI) and other indices and anthropometric parameters in university students. Rocz Panstw Zakl Hig. 2019;70(3):267-75.

Gomez-Peralta F, Abreu C, Cruz-Bravo M. Relationship between "a body shape index (ABSI)" and body composition in obese patients with type 2 diabetes. Diabetol Metab Syndr. 2018;10:21.

Bertoli S, Leone A, Krakauer NY. Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults. PLoS One. 2017;12(9):e0185013.